Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. Nigerian Journal of Physiological Sciences, [S. l.], v. 40, n. 2, 2026. DOI: 10.54548/. Disponível em: https://ojshostng.com/index.php/njphysiologicalsciences/article/view/4001. Acesso em: 12 avr. 2026.